These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 829484)

  • 1. Experimental investigations of bacteriological mechanisms in short course chemotherapy.
    Dickinson JM; Mitchison DA
    Bull Int Union Tuberc; 1976; 51(1):79-86. PubMed ID: 829484
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of resistance to rifampicin by pyrazinamide in experimental tuberculosis in the mouse].
    Grosset J; Truffot-Pernot C; Poggi S; Lecoeur H; Chastang C
    Rev Mal Respir; 1985; 2(4):205-8. PubMed ID: 3937188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of the action of drugs in the short-course chemotherapy].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):36-40. PubMed ID: 2416374
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy].
    Mitchison DA; Dickinson JM
    Bull Int Union Tuberc; 1978 Dec; 53(4):270-5. PubMed ID: 115526
    [No Abstract]   [Full Text] [Related]  

  • 9. [The latest topics concerning pyrazinamide].
    Kekkaku; 1985 Nov; 60(11):585-603. PubMed ID: 3937931
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
    Lucchesi M; Mancini P; Zubiani M
    Ann Ist Carlo Forlanini; 1967; 27(2):119-36. PubMed ID: 4973676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of antibacterial preparations on growth of Mycobacterium tuberculosis in a model of primary tuberculous infection in tissue culture].
    Kunichan AD; Sokolova GB; Shapatava MN
    Probl Tuberk; 1994; (5):40-3. PubMed ID: 7870726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of rifampicin on the intra- and extracellularly located Mycobacterium tuberculosis].
    Pavlov EP; Tushov EG; Kotliarov LM
    Probl Tuberk; 1974; (12):64-7. PubMed ID: 4216898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persisters and chemotherapy in tuberculous infection (author's transl)].
    Kanai K
    Kekkaku; 1978 Dec; 53(12):557-67. PubMed ID: 106180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathomorphology of experimental tuberculosis induced by rifampicin-resistant mycobacteria].
    Vidin NB; El'shanskaia MP
    Probl Tuberk; 1972; 50(7):63-7. PubMed ID: 4626207
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the activity of the new antitubercular drugs: Pyrazinamide, rifomycin, 11.072 R. P].
    Manowska W
    Gruzlica; 1968 Apr; 36(4):387-8. PubMed ID: 4971135
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance of tubercle bacilli to rifampicin in experimental tuberculosis induced in laboratory animals].
    Janowiec M; Wierzejska H
    Gruzlica; 1973 Mar; 41(3):251-7. PubMed ID: 4633122
    [No Abstract]   [Full Text] [Related]  

  • 20. Significant increases in the levels of liver enzymes in mice treated with anti-tuberculosis drugs.
    Lenaerts AJ; Johnson CM; Marrieta KS; Gruppo V; Orme IM
    Int J Antimicrob Agents; 2005 Aug; 26(2):152-8. PubMed ID: 15953708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.